StockData
Abeona Therapeutics Inc. logo

Abeona Therapeutics Inc. (ABEO) stock

ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3028% below fair value
$2.60+0.00 (0.00%)

Close on Nov 17, 2026Market cap $148.68MP/E –Yield –

Abeona Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Abeona Therapeutics's price to sales ratio was 5.2× on Nov 11, 2026, against 52.3× a year earlier. Over the last 5 years it ranged from 1.9× to 465.0×, with a median of 53.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.2×−26.2
2024Apr 30, 202431.4×−7.1
2023Apr 28, 202338.5×+21.5
2021Apr 30, 202117.0×−36.3
2019Oct 31, 201953.3×−69.4
2018Dec 31, 2018122.7×−240.0
2017Jul 31, 2017362.7×+174.6
2016Dec 30, 2016188.2×+186.2
2015Jan 30, 20151.9×−0.2
2014Dec 31, 20142.1×−0.1
2013Dec 31, 20132.2×+0.7
2012Dec 31, 20121.5×–

More Abeona Therapeutics figures

See a number that looks wrong?